Prostate cancer - Cyberknife radiosurgery treats effectively and with little side effects

Press Releases

The European Cyberknife Center in Munich-Grosshadern is one of the most experienced institutions of radiosurgery worldwide

Munich, March 2015 – As of now, the European Radiosurgery Center Munich-Grosshadern (ECZM) in cooperation with the Department of Urology, Klinikum Grosshadern, University of Munich, treats low and intermediate risk prostate cancer with Cyberknife. This modern technology kills prostate cancer effectively with little side effects. The Cyberknife technology is based on an integration of an image guided system and a robotic radiation delivery unit. Due to its high end technology, Cyberknife tracks the tumor with submillimeter precision while protecting surrounding healthy tissue and organs. The ECZM has an extensive experience in treating patients with benign or malignant tumors in over 8,000 cases overall. A Cyberknife treatment may be an effective alternative to conventional therapies for prostate cancer.

Direct contact
to Cyberknife

  • Call in

  • Contact sheet

Your direct contact to

+49 89 45 23 36 -0

  1. contact sheet
    1. Data transmission

      If you want to send us your images or reports online,
      request a login to our data upload here:

European Radiosurgery Center Munich
Max Lebsche Platz 31
D - 81377 Munich, Germany


Contact us

Imprint  |  Privacy policy